Aflac (NYSE:AFL) Given New $102.00 Price Target at Evercore ISI

Aflac (NYSE:AFL) had its target price dropped by investment analysts at Evercore ISI from $104.00 to $102.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has an “underperform” rating on the financial services provider’s stock. Evercore ISI’s price objective indicates a potential downside of 5.33% from the company’s previous close.

Several other research analysts have also weighed in on AFL. JPMorgan Chase & Co. upped their price objective on shares of Aflac from $85.00 to $90.00 and gave the company a “neutral” rating in a research note on Thursday, October 3rd. UBS Group upped their price target on shares of Aflac from $84.00 to $109.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 14th. TD Cowen assumed coverage on Aflac in a research report on Wednesday, October 9th. They set a “hold” rating and a $102.00 price objective for the company. Piper Sandler upped their target price on Aflac from $114.00 to $122.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 2nd. Finally, Morgan Stanley raised their price target on Aflac from $91.00 to $98.00 and gave the stock an “equal weight” rating in a research note on Monday, August 19th. Three analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat.com, Aflac presently has a consensus rating of “Hold” and a consensus price target of $98.73.

Aflac Stock Performance

Shares of Aflac stock opened at $107.74 on Wednesday. Aflac has a 12 month low of $75.07 and a 12 month high of $115.50. The company has a quick ratio of 0.08, a current ratio of 0.08 and a debt-to-equity ratio of 0.32. The stock has a market cap of $59.85 billion, a PE ratio of 16.23, a price-to-earnings-growth ratio of 2.04 and a beta of 0.97. The business has a fifty day simple moving average of $111.11 and a 200-day simple moving average of $102.01.

Aflac (NYSE:AFL) last announced its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $2.16 EPS for the quarter, topping analysts’ consensus estimates of $1.69 by $0.47. The firm had revenue of $2.95 billion during the quarter, compared to analyst estimates of $4.30 billion. Aflac had a return on equity of 16.34% and a net margin of 22.02%. The business’s quarterly revenue was down 40.4% compared to the same quarter last year. During the same period last year, the company posted $1.84 EPS. On average, sell-side analysts anticipate that Aflac will post 7.27 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of AFL. Y.D. More Investments Ltd acquired a new stake in shares of Aflac in the second quarter valued at about $25,000. Darwin Wealth Management LLC acquired a new stake in Aflac in the 3rd quarter valued at approximately $34,000. Raelipskie Partnership bought a new position in Aflac in the 3rd quarter worth approximately $38,000. Covestor Ltd lifted its holdings in shares of Aflac by 41.8% during the third quarter. Covestor Ltd now owns 363 shares of the financial services provider’s stock worth $41,000 after buying an additional 107 shares during the last quarter. Finally, Kennebec Savings Bank bought a new stake in shares of Aflac in the third quarter valued at approximately $45,000. 67.44% of the stock is currently owned by institutional investors and hedge funds.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.